New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareVesilute vs Oxytocin

Vesilute vs Oxytocin

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & Longevity
Vesilute
Cognitive EnhancementSexual Health & Libido
Oxytocin
Summary
Vesilute is a tetrapeptide bioregulator (Lys-Glu-Asp-Leu) developed by Professor Vladimir Khavinson, tissue-specific for the retina and visual system. It supports retinal cell function, promotes normalization of photoreceptor protein synthesis, and is studied for age-related macular degeneration (AMD), retinal aging, and vision preservation in the elderly.
Oxytocin is a 9-amino acid neuropeptide produced in the hypothalamus with diverse roles in social bonding, trust, stress reduction, and sexual function. Exogenous administration is used therapeutically to improve social cognition, reduce anxiety, and enhance intimacy.
Half-Life
Short (minutes); sustained gene-regulatory effects
~3–5 minutes (IV); ~30–60 minutes (intranasal, CNS effects persist longer)
Admin Route
SubQ, Oral
Intranasal, SubQ, IV
Research
Typical Dose
10 mg per day
20–40 IU
Frequency
Daily for 10–30 days
As needed (not daily long-term)
Key Benefits
  • Supports retinal photoreceptor cell function and survival
  • May slow progression of age-related macular degeneration
  • Reduces retinal cell apoptosis from oxidative stress and aging
  • Anti-aging effects on retinal pigment epithelium
  • Potential support in diabetic retinopathy management
  • Preserves visual acuity with aging
  • Complementary to lutein, zeaxanthin, and NAD+ in ocular health protocols
  • Enhances social bonding and trust
  • Reduces social anxiety and fear of rejection
  • Improves autism spectrum symptoms (social cognition)
  • Reduces cortisol and stress reactivity
  • Enhances sexual arousal and intimacy
  • Promotes maternal behavior and bonding
  • May improve depressive symptoms
  • Appetite suppression and metabolic effects
Side Effects
  • Generally well tolerated
  • Mild injection site reactions
  • No significant ocular adverse events reported at standard doses
  • Mild uterine cramping (avoid in pregnancy)
  • Nasal irritation (intranasal)
  • Headache
  • Potential emotional over-attachment or jealousy amplification
  • +2 more
Stacks With